Clinical Trials Browser

Histiocytic Neoplasms × ulixertinib × 30 days × Clear all

NCT06411821 2026-05-28

Ulixertinib in People With Histiocytic Neoplasms

Phase 2 Recruiting

Histiocytic Neoplasms